Risk factors of hospitalization and readmission of patients with COPD exacerbation - Systematic review

International Journal of COPD

Volumn 2, Issue 3, 2007, Pages 241-251

  Bahadori, Katayoon ^a   FitzGerald, J Mark ^a,b  

^a VANCOUVER COASTAL HEALTH RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

COPD exacerbations; Hospitalizations; Readmission; Risk of admission

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; OXYGEN; PSYCHOTROPIC AGENT; SHORT ACTING DRUG;

BIOSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CINAHL; CLINICAL TRIAL; COCHRANE LIBRARY; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG MEGADOSE; DYSPNEA; EARLY INTERVENTION; EMBASE; HEALTH STATUS; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; INFORMATION RETRIEVAL; LONG TERM CARE; MEDLINE; META ANALYSIS; OXYGEN THERAPY; PHYSICAL ACTIVITY; PREDICTION; PSYCINFO; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SELF CARE; SYSTEMATIC REVIEW;

AGED; CLINICAL TRIALS AS TOPIC; FEMALE; HOSPITALIZATION; HUMANS; MALE; PATIENT READMISSION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS;

EID: 36148966167     PISSN: 11769106     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Andersson I, Johansson K, Larsson S, Pehrsson K. 2002. Long-term oxygen therapy and quality of life in elderly patients hospitalized due to severe exacerbation of COPD. A 1 year follow-up study. Respiratory Medicine, 96:944-9.
2. Anthonisen NR. 2000. Smoking, lung function and mortality. Thorax, 55: 729-30.
3. Bourbeau J, Ernst P, Cockcoft D, Suissa S. 2003. Inhaled corticosteroids and hospitalisation due to exacerbation of COPD. European Respiratory Journal, 22:286-9.
4. Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA, Maslen TK. 2000. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ, 320:1297-303.
5. Calverley PMA, Anderson JA, Celli B, et al; for the TORCH investigators. 2007. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. The New England Journal of Medicine, 356:775-789.
6. Cao Z, Ong KC, Eng P, Tan WC, Ng TP. 2006. Frequent hospital readmissions for acute exacerbation of COPD and their associated factors. Respirology, 11:188-95.
7. Connolly MJ, Lowe D, Anstey K, Hosker HSR, Pearson MG, Roberts CM. 2006. Admissions to hospital with exacerbations of chronic obstructive pulmonary disease: effect of age related factors and service organization. Thorax, 61:843-8.
8. Connors AF, Dawson NV, Thomas C, Harrell FE, Desbiens N, Fulkerson WJ, Kussin P, Bellamy P, Goldman L, Knaus WA. 1996. Outcomes following acute exacerbation of severe chronic obstructive lung disease. American Journal of Respiratory & Critical Care Medicine, 154:959-67.
9. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR. 1991. Publication bias in clinical research. Lancet, 337:867-72.
10. Fletcher CM, Peto R, Tinker CM, Speizer FE. 1976. Natural history of chronic bronchitis and emphysema. Oxford: Oxford University Press. 272 p.
11. Gadoury MA, Schwartzman K, Rouleau M, Maltais F, Julien M, Beaupré A, Renzi P, Bégin R, Nault D, Bourbeau J. 2005. Self-management reduces both short-and long-term hospitalisation in COPD. Eur Respir J, 26:853-7.
12. Garcia-Aymerich J, Barreiro E, Farrero E, Marrades RM, Morera J, Anto JM. 2000. Patients hospitalized for COPD have a high prevalence of modifiable risk factors for exacerbation. European Respiratory Journal, 16:1037-42.
13. Garcia-Aymerich J, Monso E, Marrades RM, Escarrabill J, Felez MA, Sunyer J. Anto JM. 2001. Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. EFRAM study. American Journal of Respiratory & Critical Care Medicine, 164:1002-7.
14. Garcia-Aymerich J, Farrero E, Felez MA, Izquierdo J, Marrades RM. Anto JM. 2003. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax, 58:100-5.
15. Groenewegen KH, Schols AM, Wouters EF. 2003. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest, 124:459-67.
16. Gudmundsson G, Gislason T, Janson C, Lindberg E, Hallin R, Ulrik C S, Brøndum E, Nieminen MM, Aine T, Bakke P. 2005. Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J, 26:414-19.
17. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. 1996. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials, 17:1-12.
18. Keistinen T, Vilkman S, Tuuponen T, Kivela SL. 1996. Hospital admissions for chronic obstructive pulmonary disease in the population aged 55 years or over in Finland during 1972-1992. Public Health, 110:257-9.
19. Kessler R, Faller M, Fourgaut G, Mennecier B, Weitzenblum E. 1999. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. American Journal of Respiratory & Critical Care Medicine, 159:158-64.
20. Lau AC, Yam LY, Poon E. 2001. Hospital re-admission in patients with acute exacerbation of chronic obstructive pulmonary disease. Respiratory Medicine, 95:876-84.
21. MacKay M, Reid DC, Moher D, Klassen T. 2003. Systematic Review of the Relationship Between Childhood Injury and Socio-economic Status. NICE - Public Health Evidence.
22. Mannino DM. 2002. COPD: Epidemiology, Prevalence, Morbidity and Mortality, and Disease Heterogeneity. Chest, 121:121-6.
23. Miravitlles M, Guerrero T, Mayordomo C, Sanchez-Agudo L, Nicolau F, Segu JL. 2000. Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. The EOLO Study Group. Respiration, 67:495-501.
24. Miravitilles M, Calle M, Alvarez-Gutierrez F, Gobartt E, Lo'pez F, Marti'n A. 2006. Exacerbations, hospital admissions and impaired health status in chronic obstructive pulmonary disease. Quality of Life Research, 15: 471-80.
25. Moher D, Cook DJ, Eastwood S, Olkin L, Rennie D, Stroup DF. 1999. Improving the quality of reports of meta-analysis of randomized controlled trials: the QUOROM statement. Lancet, 345:1896-900.
26. Murlow C, Cook D. 1998. Systematic Reviews: Synthesis of Best Evidence for Health Care Decisions. Philadelphia American College of Physicians, 129:759-60.
27. Murray CJ, Lopez AD. 1997. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet, 349:1498-504.
28. Oostenbrink JB, Rutten-van Molken W. 2004. Resource use and risk factors in high-cost exacerbations of COPD. Respir Med, 98:883-91.
29. Pouw EM, Ten Velde GP, Croonen BH, Kester AD, Schols AM, Wouters EF. 2000. Early non-elective readmission for chronic obstructive pulmonary disease is associated with weight loss. Clinical Nutrition, 19:95-9.
30. Ringbaek TJ, Viskum K, Lange P. 2002. Does long-term oxygen therapy reduce hospitalisation in hypoxaemic chronic obstructive pulmonary disease? European Respiratory Journal, 20:38-42.
31. Schols AMWJ, Slangen J, Volovics L, Wouters EFM. 1998. Weight Loss Is a Reversible Factor in the Prognosis of Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit Care Med, 157:1791-7.
32. Seermungal T, Donaldson G, Paul E, Bestall J, Jeffries D, Wedzicha. 1998. JADW: Effect of Exacerbation on Quality of Life in Patients with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med, 157:1418-22.
33. Seemungal TAR, Donaldson GC, Wedzicha JA. 2000. Exacerbations and the risk of hospitalisation in patients with COPD. Thorax, 55:A44.
34. Slavin RE. 1995. Best evidence synthesis: an intelligent alternative to meta-analysis. J clin Epidemiol, 48:9-18.
35. Soler-Cataluña JJ, Martínez-García MÁ, Román Sánchez P, Salcedo E, Navarro M, Ochando R. 2005. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax, 60:925-31.
36. Wang Q, Bourbeau J. 2005. Outcomes and health-related quality of life following hospitalization for an acute exacerbation of COPD. Respirology, 10:334-40.
37. Wilkinson TMA, Donaldson GC, Hurst JR, Seemungal TAR, Wedzicha JA. 2004. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. American Journal of Respiratory & Critical Care Medicine, 169:1298-303.